One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
Background: Bivalirudin reduces ischemic and hemorrhagic events in patients undergoing primary percutaneous coronary intervention (PCI), but the safety and efficacy for such individuals are unclear. Our aim was to evaluate the long-term safety and efficacy of bivalirudin in patients undergoing elect...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
IMR Press
2023-07-01
|
| Серія: | Reviews in Cardiovascular Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.imrpress.com/journal/RCM/24/8/10.31083/j.rcm2408218 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|